Ticagrelor — a legend of modern cardiology

Ticagrelor — a legend of modern cardiology

The article presents the evidence on the basis of which the ticagrelor is used in patients with various forms of coronary artery disease, including both acute and chronic. Evidence is provided to support the benefits of ticagrelor over clopidogrel in patients with acute coronary syndrome, as well as...

Full description

Saved in:

Bibliographic Details
Main Author:	S. R. Gilyarevsky
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-10-01
Series:	Российский кардиологический журнал
Subjects:	ticagrelor p2y12 inhibitors acute coronary syndrome chronic coronary syndrome pleiotropic effects
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/6052
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention
by: Dunya Habeeb Shnain, et al.
Published: (2024-06-01)

Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction
by: Darae Ko, et al.
Published: (2024-08-01)

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety
by: Fadel Bahouth, et al.
Published: (2025-05-01)

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
by: N. M. Vorobyeva
Published: (2019-01-01)

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

Cost analysis of dual antiplatelet therapy with prasugrel and ticagrelor in patients with acute coronary syndrome after percutaneous coronary intervention
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Statins in clinical practice
by: A. S. Sivkov, et al.
Published: (2010-04-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS study
by: Tony Haddad, et al.
Published: (2025-12-01)

EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
by: Roman M. Shakhnovich
Published: (2018-12-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
by: Hamidreza Soleimani, et al.
Published: (2025-04-01)

P2Y12 Inhibitor‐Based Single Antiplatelet Therapy Versus Conventional Dual Antiplatelet Therapy After Newer‐Generation Drug‐Eluting Stent Implantation in Chronic and Acute Coronary Syndromes: A Systematic Review and Meta‐Analysis of Randomized Clinical Trials
by: Juan F. Iglesias, et al.
Published: (2025-03-01)

Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel
by: Mark A. Sammut, et al.
Published: (2025-12-01)

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)
by: S. N. Tereshchenko, et al.
Published: (2019-11-01)

SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME
by: A. D. Erlikh
Published: (2017-05-01)

Effect of Ticagrelor on Glycaemic Parameters and Inflammatory Mediators in High Fat Diet and Streptozotocin Induced Diabetic Rats: An Experimental Study
by: Sachin Patel, et al.
Published: (2025-08-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Intravenous nitrates in modern cardiology
by: I. V. Zhirov, et al.
Published: (2005-12-01)

Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI
by: Can Zhou, et al.
Published: (2025-04-01)

Consequences of escalation and de-escalation of double antiplatelet therapy in patients with acute coronary syndrome in real clinical practice
by: R. L. Shamraev, et al.
Published: (2019-04-01)

Extended dual antithrombotic therapy in patients with chronic coronary syndrome — which agent should be added to aspirin?
by: Jacek Kubica, et al.
Published: (2025-06-01)

CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE
by: A. I. Akhmetova, et al.
Published: (2017-12-01)

Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis
by: Liyuan Wang, et al.
Published: (2025-05-01)

NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: K. B. Mirzaev, et al.
Published: (2018-03-01)

Effect of Ticagrelor Versus Clopidogrel After Off‐Pump Coronary Artery Bypass Grafting on Postoperative Atrial Fibrillation: A Cohort Study
by: Qin Jiang, et al.
Published: (2024-08-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

Ticagrelor in patients with stable coronary artery disease: a role in improving prognosis
by: T. N. Novikova
Published: (2020-09-01)

Effectiveness of clopidogrel vs. ticagrelor based on the ABCD-GENE score in acute coronary syndrome patients following percutaneous coronary intervention
by: Xiaotong Xu, et al.
Published: (2025-06-01)

Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial
by: I. S. Yavelov
Published: (2022-02-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

Antiplatelet therapy de-escalation in a patient after percutaneous coronary intervention with a high risk of bleeding
by: A. A. Kassymova, et al.
Published: (2023-06-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group
by: Perel Nimrod, et al.
Published: (2025-08-01)

TETANIC CRISIS IN EMERGENCY CARDIOLOGY — DIFFICULTIES DIFFERENTIAL DIAGNOSIS OF ACUTE CORONARY SYNDROME
by: V. V. Rezvan, et al.
Published: (2016-10-01)

Takotsubo Syndrome in a Patient With a Malignant Tumor of the Kidney
by: N. V. Rutkovskaya, et al.
Published: (2020-10-01)

Ticagrelor combined with aspirin may improve patency of vein graft one year after off-pump coronary artery bypass grafting: a single-center, randomized double-blinded clinical controlled trial
by: Wenjun Wang, et al.
Published: (2025-05-01)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

OPTIMISATION OF ARTERIAL HYPERTENSION PHARMACOTHERAPY IN PATIENTS WITH METABOLIC SYNDROME: POTENTIAL OF ZOFENOPRIL
by: T. E. Morozova, et al.
Published: (2011-08-01)